These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9684757)

  • 1. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Thromb Res; 1998 Apr; 90(2):51-6. PubMed ID: 9684757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera].
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Orv Hetil; 1996 Jan; 137(2):71-4. PubMed ID: 8721871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis.
    Cancelas JA; García-Avello A; García-Frade LJ
    Thromb Res; 1994 Sep; 75(5):513-20. PubMed ID: 7992252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
    Rusak T; Piszcz J; Misztal T; Brańska-Januszewska J; Tomasiak M
    Thromb Res; 2014 Jul; 134(1):192-8. PubMed ID: 24824295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasma.
    Serizawa K; Urano T; Kozima Y; Takada Y; Takada A
    Thromb Res; 1993 Aug; 71(4):289-300. PubMed ID: 8236158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic imbalance in essential thrombocythemia: role of platelets.
    Bazzan M; Tamponi G; Gallo E; Stella S; Schinco PC; Pannocchia A; Pileri A
    Haemostasis; 1993; 23(1):38-44. PubMed ID: 8477907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus.
    Udvardy M; Posan E; Harsfalvi J
    Thromb Res; 1995 Jul; 79(1):57-63. PubMed ID: 7495104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.
    Panova-Noeva M; Marchetti M; Spronk HM; Russo L; Diani E; Finazzi G; Salmoiraghi S; Rambaldi A; Barbui T; Ten Cate H; Falanga A
    Am J Hematol; 2011 Apr; 86(4):337-42. PubMed ID: 21442635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera.
    Karakantza M; Giannakoulas NC; Zikos P; Sakellaropoulos G; Kouraklis A; Aktypi A; Metallinos IC; Theodori E; Zoumbos NC; Maniatis A
    Int J Hematol; 2004 Apr; 79(3):253-9. PubMed ID: 15168594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of platelets and leukocytes in coagulation and fibrinolysis.
    Cucuianu M; Trif I
    Rev Roum Physiol (1990); 1992; 29(1-2):33-8. PubMed ID: 1472550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.